Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal intelligence from Strategic Transactions.
Pfizer Inc., Merck KGAA and eFFECTOR Therapeutics Inc. entered into a trial collaboration agreement on June 20...








